Severo Salvadori focuses on Receptor, Nociceptin receptor, Peptide, Stereochemistry and Pharmacology. His biological study spans a wide range of topics, including Biological activity and In vitro. His Nociceptin receptor study integrates concerns from other disciplines, such as Agonist, -Naloxone, Antagonist and Endocrinology.
His work deals with themes such as Protein structure, Gene, Immunology and Dermorphin, which intersect with Peptide. His Stereochemistry study integrates concerns from other disciplines, such as Tripeptide, Dipeptide, Chemical synthesis and Peptide synthesis. The concepts of his Pharmacology study are interwoven with issues in Orphanin FQ, Nociceptin-orphanin FQ, NOP, Neuropeptide and Opioid.
Severo Salvadori mainly focuses on Stereochemistry, Receptor, Peptide, Agonist and Opioid peptide. Severo Salvadori interconnects Biological activity, Dermorphin, Opioid and Peptide synthesis in the investigation of issues within Stereochemistry. His Receptor research is multidisciplinary, incorporating perspectives in Endocrinology and Pharmacology.
His Endocrinology research integrates issues from -Naloxone and Ligand. His study in Peptide is interdisciplinary in nature, drawing from both Amino acid, Combinatorial chemistry, Protein structure and Carboxamide. His work deals with themes such as Selectivity, Structure–activity relationship, Opioid receptor and δ-opioid receptor, which intersect with Opioid peptide.
Receptor, Stereochemistry, Pharmacology, Peptide and Biological activity are his primary areas of study. Receptor is a subfield of Internal medicine that Severo Salvadori explores. His Stereochemistry research is multidisciplinary, relying on both Combinatorial chemistry, Structure–activity relationship, Opioid peptide and Opioid receptor.
His work carried out in the field of Pharmacology brings together such families of science as Neuropeptide S, Mitochondrion and Agonist. His Peptide study combines topics from a wide range of disciplines, such as Nociceptin receptor, Molecular biology and Nociceptin-orphanin FQ. Severo Salvadori has included themes like NOP and In vitro in his Nociceptin receptor study.
His primary areas of investigation include Receptor, Pharmacology, Endocrinology, Internal medicine and Peptide. His studies deal with areas such as Hippocampus and Neuroscience as well as Receptor. His work is dedicated to discovering how Pharmacology, Agonist are connected with Analgesic, Opioid peptide, Naltrexone, -Naloxone and Opioid and other disciplines.
His Endocrinology research incorporates themes from Neurotrophic factors, Opioid receptor and Neuroprotection. His studies in Peptide integrate themes in fields like NOP, In vitro, Nociceptin receptor and Dihydrofolate reductase. His NOP research focuses on Tetra and how it relates to Combinatorial chemistry, Biological activity and Stereochemistry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Tachykinin Peptide Family
Cinzia Severini;Giovanna Improta;Giuliana Falconieri-Erspamer;Severo Salvadori.
Pharmacological Reviews (2002)
Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.
Orlando Crescenzi;Simona Tomaselli;Remo Guerrini;Severo Salvadori.
FEBS Journal (2002)
Pharmacology of nociceptin and its receptor: a novel therapeutic target
Girolamo Calo;Remo Guerrini;Anna Rizzi;Severo Salvadori.
British Journal of Pharmacology (2000)
A new selective antagonist of the nociceptin receptor
Remo Guerrini;Girolamo Calo;Anna Rizzi;Raffaella Bigoni.
British Journal of Pharmacology (1998)
Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide.
Remo Guerrini;Girolamo Calo;Anna Rizzi;Clementina Bianchi.
Journal of Medicinal Chemistry (1997)
Characterization of [Nphe1]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist
Girolamo Calo;Remo Guerrini;Raffaella Bigoni;Anna Rizzi.
web science (2000)
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
Girolamo Calo;Anna Rizzi;Daniela Rizzi;Raffaella Bigoni.
web science (2002)
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile
ND Dietis;R Guerrini;G Calo;s Salvadori.
BJA: British Journal of Anaesthesia (2009)
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice
A Rizzi;R Vergura;G Marzola;C Ruzza.
British Journal of Pharmacology (2009)
The mouse vas deferens: a pharmacological preparation sensitive to nociceptin.
Girolamo Calò;Anna Rizzi;Giovanni Bogoni;Vitold Neugebauer.
European Journal of Pharmacology (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: